This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
Close
Tablets
Capsules
Dose Adjustments & Escalations
Dosing
Tab Number 5
Tablets
Capsules
For patients who are unable to swallow capsules, the contents of the capsules can be mixed with applesauce or yogurt.
Remove the required number of capsules from the container to prepare the dose as instructed and the amount of either room-temperature applesauce or yogurt in a clean container
Carefully open each capsule, add the entire capsule content of each capsule into the applesauce or yogurt, then mix the entire dose into the applesauce or yogurt
Patients should immediately consume the full mixture in its entirety, without chewing. Do not store the mixture for later use. If the entire preparation is not swallowed, do not take an additional dose. Wait until the next day to resume dosing
100 mg: white body/brownish-red cap with “BOS 100” printed on the body and “Pfizer” printed on the cap in black ink.
Bosutinib is a tyrosine kinase inhibitor
The MyTherapy® App includes a section dedicated to BOSULIF patients to support them with medication reminders, treatment tracking, and helpful resources
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.
Adult and pediatric patients 1 year of age and older with chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), newly-diagnosed or resistant or intolerant to prior therapy
BOSULIF is indicated for the treatment of:
Adult and pediatric patients 1 year of age and older with chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), newly-diagnosed or resistant or intolerant to prior therapy